Meeting the UNAIDS 2030 targets could prevent 3.3 million new #HIV infections by 2030. 🌍

This depends on timely, affordable, and sustainable access across markets, and public health–oriented #voluntarylicensing is a proven way to help achieve it.

👉 https://medicinespatentpool.org/

#CROI2026

#RSV remains a major cause of infant illness and death worldwide 🌍, disproportionately affecting LMICs.

Public health–oriented #voluntarylicensing, used in other disease areas, can help enable earlier access in these settings.

📩 science@medicinespatentpool.org

MPP welcomes the updated @who.int Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc).

We remain committed to enabling #access to essential medicines through #voluntarylicensing, #technologytransfer, and #manufacturing support.

👉 lnkd.in/dmr98RHf

Taking HIV pills daily can be overwhelming. 💉 Long-acting injectables offer hope, safe and effective. LMICs still lack timely access. #Voluntarylicensing can change that, ensuring the most vulnerable benefit from innovation.

📖 www.sciencedirect.com/science/arti...

👉 www.youtube.com/watch?v=GGDM...

🌍 How can we ensure life-saving medicines reach all who need them, benefiting patients, originators, and generics alike?

💬 In this episode of @wipo.int’s Mission Imagination, Charles Gore shares how MPP’s #voluntarylicensing model is driving global health impact.

🎥 www.youtube.com/watch?v=im9q...